The decline in mRNA is short-lived

OYoung
2021-08-06

In 2020 and early 2021, dips for Moderna typically persisted for weeks and in a couple of times, for months. In stark contrast, after Moderna's entry to the S&P, dips are short lived, typically lasting only for hours or even mere minutes. Sure interested retail investors who want in are crossing their fingers calmly waiting for the best possible bargain (very reasonable if you ask me), but institutional investors simply are not interested in waiting, they just keep on buying. Bad news for the Michael Burry wannabe trolls on this board.$Moderna, Inc.(MRNA)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment